Skip to content
Dr. Nguyen Dai Phong

How many kinds of sleeping pill are there

Six groups of sleep medication, how their mechanisms differ, which are recommended and which are not.

Updated 2026-11-03 · 9 min read

How many kinds of sleeping pill are there

Key points

  • Six main groups with entirely different mechanisms, and they are not interchangeable.
  • International guidelines rate every recommendation to use medication for insomnia as WEAK, the recommended drugs included.
  • Some of the most popular options are NOT recommended: melatonin, valerian, L-tryptophan, sedating antihistamines, and trazodone.
  • ⛔ This page is NOT a guide to choosing a medicine yourself. The choice depends on the diagnosis, other conditions, age and everything else you are taking.

Why the groups matter to a patient

Not so that you can choose for yourself, but so that you understand why a doctor asks carefully about the kind of insomnia you have before discussing medication. A short-acting drug suits someone who cannot FALL asleep; a longer-acting one suits someone who cannot STAY asleep. Used the wrong way round, it either does not last long enough or leaves you drowsy until midday.

The six groups

1. Benzodiazepines

The oldest group, acting broadly on the central nervous system through the GABA-A receptor. Sedating, anxiolytic and muscle-relaxing at once. That breadth of action is the source of both the effect and the problems: dependence, tolerance, rebound insomnia on stopping, and a risk of falls in older people.

2. Z-drugs, the non-benzodiazepines

Acting more selectively on part of the GABA-A receptor, so with less muscle relaxation and less anxiolytic effect. Very widely used. In 2019 the US drug regulator added a boxed warning to three drugs in this group because of complex sleep behaviours, walking, driving and cooking while not fully awake, which can lead to serious injury and death.

3. Dual orexin receptor antagonists

A newer group with an entirely different mechanism. Rather than suppressing the whole brain, it blocks orexin, the signal holding the brain in a waking state. Picture it this way: the older groups press the brake, this one lifts off the accelerator. In theory that produces sleep closer to the physiological kind.

4. Low-dose sedating antidepressants

Some antidepressants at very low doses have a strong antihistamine effect and are used for insomnia. The 2017 guideline weakly recommends one drug in this group for sleep maintenance, but does not recommend trazodone, even though it is very commonly prescribed for insomnia in many places.

5. Melatonin receptor agonists

Acting on the same receptor that endogenous melatonin binds to, but as prescription drugs with quite different pharmacokinetic properties from supplemental melatonin. Weakly recommended for trouble falling asleep.

6. Over-the-counter antihistamines and herbal products

This is the group patients self-medicate with the most and the one with the weakest evidence. International guidelines do not recommend diphenhydramine, melatonin, valerian or L-tryptophan for chronic insomnia. Antihistamines additionally carry an anticholinergic burden that matters in older people.

Summary table

GroupSuits which patternPosition in the guidelines
BenzodiazepinesDepends on the drugA few of them, WEAK recommendation
Z-drugsFalling asleep and/or staying asleep, depending on the drugWEAK recommendation; carries a boxed warning
Dual orexin antagonistsFalling asleep and staying asleepA newer group, closer to physiological sleep
Low-dose antidepressantsStaying asleepOne drug weakly recommended; trazodone NOT recommended
Melatonin agonistsFalling asleepWEAK recommendation
Antihistamines, herbal products - NOT recommended

Duration of action matters more than people think

Within the same group, differences in duration of action make a large difference to who a drug suits. A short-acting drug suits someone who cannot FALL asleep but sleeps afterwards; a longer-acting one suits someone who cannot STAY asleep.

Getting the direction wrong has two different consequences. A drug that is too short-acting for someone waking at 3am has already worn off before the problem happens. A drug that is too long-acting for someone who only struggles to fall asleep leaves them drowsy the next morning, with slowed reactions and a higher risk of falls, in older people above all.

Questions worth asking when you are prescribed something

  1. Which part of my problem is this aimed at, falling asleep, staying asleep, or both?
  2. How long am I expected to take it, and what is the plan for stopping?
  3. Which unwanted effects should I know about, and which signs mean calling you straight away?
  4. Does it interact with anything else I am taking?
  5. If I want to reduce the dose later, how is that done?

The second question is the most important and the least often asked. A prescription for a sleeping pill with no plan for stopping very easily becomes a long-term prescription that nobody ever decided on.

Frequently asked questions

Which group is best?
There is no best group for everyone. The choice depends on the pattern of insomnia, other conditions, age and other medicines. And for chronic insomnia, the first-line choice under the guidelines is not a medicine at all.
Why is every recommendation weak?
A weak rating reflects a benefit that is real but modest against the risks, and that different patients will weigh it differently. That is important information and it is rarely said out loud.
Is a sedative the same as a sleeping pill?
Many drugs are sedating at a low dose and induce sleep at a higher one. The line is dose and purpose, not two separate classes of medicine.

References

  1. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults - American Academy of Sleep Medicine, 2017 · DOI 10.5664/jcsm.6470
  2. Boxed warning about complex sleep behaviors with eszopiclone, zaleplon, and zolpidem (Drug Safety and Availability) - U.S. Food and Drug Administration, 2019
  3. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline from the American College of Physicians - American College of Physicians, 2016 · DOI 10.7326/M15-2175
  4. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults - American Geriatrics Society, 2023 · DOI 10.1111/jgs.18372
  5. Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis - PLOS ONE, 2017
  6. The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023 - European Sleep Research Society, 2023 · DOI 10.1111/jsr.14035

Pick how you would like to reach the clinic.